Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:14
|
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] EFFICACY OF ANTIOXIDANT IN IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Kandhare, Amit D.
    Mukherjee, Anwesha
    Ghosh, Pinaki
    Bodhankar, Subhash L.
    EXCLI JOURNAL, 2016, 15 : 636 - 651
  • [22] Efficacy of traditional Chinese medicine on sepsis: a systematic review and Meta-Analysis
    Liang, Xiao
    Zhou, Miao
    Ge, Xin-Yu
    Li, Cheng-Bao
    Fang, Shang-Ping
    Tang, Ling
    Shao, Dong-Hua
    Xu, Guo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 20024 - 20034
  • [23] Traditional Chinese medicine for idiopathic membranous nephropathy: A systematic review and meta-analysis
    Shan, Wenjun
    Guan, Haiyu
    Gu, Haowen
    Wang, Rongrong
    Huang, Xiaoyan
    Li, Ping
    Xie, Ying
    Bao, Kun
    Qin, Xindong
    HELIYON, 2024, 10 (07)
  • [24] Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy: A updated meta-analysis of randomized controlled trials
    Lu, Haimei
    Luo, Mengxian
    Chen, Rongrong
    Luo, Yijun
    Xi, Anran
    Wang, Keer
    Xu, Zhenghao
    EPILEPSY RESEARCH, 2023, 189
  • [25] The efficacy and safety of traditional Chinese medicine treating diabetic cardiomyopathy: A protocol for systematic review and meta-analysis
    Han, Shuo
    Hou, Yuan
    Liu, Huaman
    Zhao, Quanlin
    MEDICINE, 2022, 101 (47) : E31269
  • [26] EFFICACY AND SAFETY OF TRADITIONAL CHINESE MEDICINE FOR ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Yuan, J.
    Li, M.
    Bai, J.
    Hu, Z.
    Zhao, J.
    Lu, K. Z.
    VALUE IN HEALTH, 2024, 27 (06) : S52 - S52
  • [27] Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials
    Xiao, Jiao
    Yang, Yunfeng
    Zhu, Yuanrong
    Qin, Yan
    Li, Yifan
    Fu, Mengjie
    Zhai, Zhengdong
    Zhu, Lingyun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [28] Efficacy and safety of traditional chinese medicine treatment for overweight and obese individuals: A systematic review and meta-analysis
    Wen, Zhi Ge
    Zhang, Qi Qi
    Zhang, Li Li
    Shen, Meng Fei
    Huang, Yi Shan
    Zhao, Lin Hua
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] A systematic review and meta-analysis on the efficacy and safety of traditional Chinese medicine bath in the treatment of psoriasis vulgaris
    Lei, Hua
    Chen, Minghui
    Zhang, Nan
    Guo, Xiaojuan
    Yuan, Xiaohui
    Tang, Lina
    Ying, Chuanpeng
    Xie, Jun
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10674 - 10683
  • [30] Efficacy and safety of traditional Chinese medicine for Tourette's syndrome: A meta-analysis of randomized controlled trials
    Qi, Han
    Liu, Rui
    Zheng, Wei
    Zhang, Ling
    Ungvari, Gabor S.
    Ng, Chee H.
    Wang, Gang
    Xiang, Yu-Tao
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 47